Literature DB >> 31850550

Transcatheter intra-arterial perfusion (TRIP)-MRI biomarkers help detect immediate response to irreversible electroporation of rabbit VX2 liver tumor.

Matteo Figini1, Kang Zhou1,2, Liang Pan1,3, Chong Sun1,4, Bin Wang1,5, Su Hu1,6, Jia Yang1, Junjie Shangguan1, Aydin Eresen1, Yury Velichko1,7, Vahid Yaghmai1,7, Zhuoli Zhang1,7.   

Abstract

PURPOSE: Irreversible electroporation (IRE) is a nonthermal tissue ablation technique that represents a promising treatment option for unresectable liver tumors, but the effectively treated zone cannot be reliably predicted. We investigate the potential benefit of transcatheter intra-arterial perfusion (TRIP) -MRI for the early noninvasive differentiation of IRE zone from surrounding reversibly electroporated (RE) zone.
METHODS: Seventeen rabbits with VX2 liver tumors were scanned with morphological and contrast-enhanced MRI sequences approximately 30 min after IRE tumor ablation. Quantitative TRIP-MRI perfusion parameters were evaluated in IRE zone and RE zone, defined according to histology. MRI and histology results were compared among zones using Wilcoxon rank-sum tests and correlations were evaluated by Pearson's correlation coefficient.
RESULTS: There were significant differences in area under the curve, time to peak, maximum and late enhancement, wash-in and wash-out rates in the tumor IRE zones compared with the boundary tumor RE zones and untreated tumors. Histology showed significantly fewer tumor cells, microvessels and significantly more apoptosis in tumor IRE zones compared with tumor RE zones (-51%, -66% and +185%, respectively) and untreated tumors (-60%, -67%, and +228%, respectively). A strong correlation was observed between MRI and histology measurements of IRE zones (r = 0.948) and RE zones (r = 0.951).
CONCLUSION: TRIP-MRI demonstrated the potential to detect immediate perfusion changes following IRE liver tumor ablation and effectively differentiate the IRE zone from the surrounding tumor RE zone.
© 2019 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  irreversible electroporation; irreversibly electroporated zone; liver tumors; rabbit; reversibly electroporated zone; transcatheter intra-arterial perfusion (TRIP)-MRI

Mesh:

Substances:

Year:  2019        PMID: 31850550      PMCID: PMC7083687          DOI: 10.1002/mrm.28104

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  36 in total

Review 1.  Local-regional treatment of hepatocellular carcinoma.

Authors:  Riccardo Lencioni; Laura Crocetti
Journal:  Radiology       Date:  2012-01       Impact factor: 11.105

2.  Contrast Enhancement Patterns after Irreversible Electroporation: Experimental Study of CT Perfusion Correlated to Histopathology in Normal Porcine Liver.

Authors:  Dong Jin Chung; Kyunghyun Sung; Ferdnand C Osuagwu; Holden H Wu; Charles Lassman; David S K Lu
Journal:  J Vasc Interv Radiol       Date:  2015-11-04       Impact factor: 3.464

3.  Tissue ablation with irreversible electroporation.

Authors:  R V Davalos; I L M Mir; B Rubinsky
Journal:  Ann Biomed Eng       Date:  2005-02       Impact factor: 3.934

4.  Diffusion MRI biomarkers predict the outcome of irreversible electroporation in a pancreatic tumor mouse model.

Authors:  Matteo Figini; Xifu Wang; Tianchu Lyu; Zhanliang Su; Bin Wang; Chong Sun; Junjie Shangguan; Liang Pan; Kang Zhou; Quanhong Ma; Vahid Yaghmai; Daniele Procissi; Andrew C Larson; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

5.  Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma.

Authors:  Dingxin Wang; Brian Jin; Robert J Lewandowski; Robert K Ryu; Kent T Sato; Mary F Mulcahy; Laura M Kulik; Frank H Miller; Riad Salem; Debiao Li; Reed A Omary; Andrew C Larson
Journal:  J Magn Reson Imaging       Date:  2010-05       Impact factor: 4.813

Review 6.  Liver Ablation: Best Practice.

Authors:  Shane A Wells; J Louis Hinshaw; Meghan G Lubner; Timothy J Ziemlewicz; Christopher L Brace; Fred T Lee
Journal:  Radiol Clin North Am       Date:  2015-09       Impact factor: 2.303

7.  Modeling of electric field distribution in tissues during electroporation.

Authors:  Selma Corovic; Igor Lackovic; Primoz Sustaric; Tomaz Sustar; Tomaz Rodic; Damijan Miklavcic
Journal:  Biomed Eng Online       Date:  2013-02-21       Impact factor: 2.819

8.  Histopathological and Ultrastructural Changes after Electroporation in Pig Liver Using Parallel-Plate Electrodes and High-Performance Generator.

Authors:  B López-Alonso; A Hernáez; H Sarnago; A Naval; A Güemes; C Junquera; J M Burdío; T Castiella; E Monleón; J Gracia-Llanes; F Burdio; E Mejía; O Lucía
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

9.  Electric Ablation with Irreversible Electroporation (IRE) in Vital Hepatic Structures and Follow-up Investigation.

Authors:  Xinhua Chen; Zhigang Ren; Tongyin Zhu; Xiongxin Zhang; Zhiyi Peng; Haiyang Xie; Lin Zhou; Shengyong Yin; Junhui Sun; Shusen Zheng
Journal:  Sci Rep       Date:  2015-11-09       Impact factor: 4.379

10.  Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer.

Authors:  M Valerio; P D Stricker; H U Ahmed; L Dickinson; L Ponsky; R Shnier; C Allen; M Emberton
Journal:  Prostate Cancer Prostatic Dis       Date:  2014-09-02       Impact factor: 5.554

View more
  5 in total

1.  Early assessment of irreversible electroporation ablation outcomes by analyzing MRI texture: preclinical study in an animal model of liver tumor.

Authors:  Aydin Eresen; Kang Zhou; Chong Sun; Junjie Shangguan; Bin Wang; Liang Pan; Su Hu; Yongsheng Pang; Zigeng Zhang; Robert Minh Nhat Tran; Ajeet Pal Bhatia; Farouk Nouizi; Nadine Abi-Jaoudeh; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

Review 2.  Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma.

Authors:  Aydin Eresen; Jia Yang; Alessandro Scotti; Kejia Cai; Vahid Yaghmai; Zhuoli Zhang
Journal:  Ann Transl Med       Date:  2021-07

Review 3.  Rabbit VX2 Liver Tumor Model: A Review of Clinical, Biology, Histology, and Tumor Microenvironment Characteristics.

Authors:  Florentina Pascale; Jean-Pierre Pelage; Michel Wassef; Saïda H Ghegediban; Jean-Pierre Saint-Maurice; Thierry De Baere; Alban Denys; Rafael Duran; Frédéric Deschamps; Olivier Pellerin; Noboru Maeda; Alexandre Laurent; Julien Namur
Journal:  Front Oncol       Date:  2022-05-10       Impact factor: 5.738

4.  Intraprocedural Transcatheter Intraarterial Perfusion (TRIP)-MRI for Evaluation of Irreversible Electroporation Therapy Response in a Rabbit Liver Tumor Model.

Authors:  Anna J Shangguan; Kang Zhou; Jia Yang; Aydin Eresen; Bin Wang; Chong Sun; Liang Pan; Su Hu; Ali T Khan; Samdeep K Mouli; Vahid Yaghmai; Zhuoli Zhang
Journal:  Clin Exp Gastroenterol       Date:  2020-11-06

Review 5.  Recent progress in pulsed electric field ablation for liver cancer.

Authors:  Zhen-Guo Liu; Xin-Hua Chen; Zu-Jiang Yu; Jun Lv; Zhi-Gang Ren
Journal:  World J Gastroenterol       Date:  2020-06-28       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.